Cargando…
Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study
Recommended strategy for venous thromboembolism (VTE) diagnosis includes the use of sensitive D-dimer (DDi) assays along with pretest probability (PTP) assessment. The Clinical and Laboratory Standards Institute (CLSI) recently issued a guideline (US FDA endorsed) on DDi in VTE exclusion. Such guide...
Autores principales: | Aguilar, Carlos, Sartori, Michelangelo, D’Angelo, Armando, Kabrhel, Christopher, Groce, James, de Maistre, Emmanuel, Wasan, Suman M., Kassis, Jeannine, Lazarchick, John, Kaide, Colin, Vera, Pascual Marco, Kline, Jeffrey, Courtney, D. Mark, Rubin, Andrew, Sharafuddin, Melhem, Pernod, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200385/ https://www.ncbi.nlm.nih.gov/pubmed/30113416 http://dx.doi.org/10.1097/MBC.0000000000000750 |
Ejemplares similares
-
Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study
por: Pernod, Gilles, et al.
Publicado: (2017) -
D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA?
por: Pernod, Gilles, et al.
Publicado: (2017) -
Complex DDI by Fenebrutinib and the Use of Transporter Endogenous Biomarkers to Elucidate the Mechanism of DDI
por: Jones, Nicholas S., et al.
Publicado: (2019) -
Anticoagulation in COVID-19: DDI Perspective
por: Khiali, Sajad, et al.
Publicado: (2020) -
Ddi1 is a ubiquitin-dependent protease
por: Yip, Matthew C. J., et al.
Publicado: (2020)